Regulatory › Drugs@FDA › History › NDA215256 Drugs@FDA application timeline
NDA215256 16 dated FDA-coded AP submissions from 2021-06-04 through 2026-06-18, connected to 19 source-defined action assignments and 33 official document links.
16 Dated AP submissions
19 Action assignments
33 Official documents
0 Exact enforcement reports
1 Reviewed profile mappings
Reporting boundary This history reports exact Drugs@FDA submission status dates, source-defined action labels, and official document metadata for applications already selected by PeptideScanner. FDA's AP code and action labels are source metadata; this page does not interpret approval scope, reproduce document text, establish safety or effectiveness, or provide medical guidance. Document links open FDA-hosted material; PeptideScanner does not copy or summarize their contents.
Reviewed identity mapping
Connected peptide profiles Newest first
Submission and document chronology 16 submissions 2026-06-18 · status AP
Supplement 25 FDA action labels Manufacturing (CMC)-Manufacturing Process
1 official document Label ↗ 2026-06-23 · FDA document 86339 2026-05-05 · status AP
Supplement 31 FDA action labels Manufacturing (CMC)-Packaging
2 official documents Review ↗ 2026-08-07 · FDA document 86830 Label ↗ 2026-05-12 · FDA document 85892 2026-03-19 · status AP
Supplement 29 FDA action labels Efficacy-New Dosing Regimen
3 official documents 2026-02-25 · status AP
Supplement 33 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
2 official documents Label ↗ 2026-03-02 · FDA document 85190 Letter ↗ 2026-02-27 · FDA document 85178 2026-01-29 · status AP
Supplement 30 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
2 official documents Letter ↗ 2026-01-30 · FDA document 84885 Label ↗ 2026-01-29 · FDA document 84943 2025-11-21 · status AP
Supplement 23 FDA action labels Efficacy-New Indication
2 official documents Label ↗ 2025-11-25 · FDA document 84296 Letter ↗ 2025-11-24 · FDA document 84279 2025-10-14 · status AP
Supplement 26 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2025-10-15 · FDA document 83779 Letter ↗ 2025-10-15 · FDA document 83774 2025-08-15 · status AP
Supplement 24 FDA action labels Efficacy-New Indication
2 official documents Letter ↗ 2025-08-18 · FDA document 83118 Label ↗ 2025-08-15 · FDA document 83106 2024-11-27 · status AP
Supplement 15 FDA action labels Efficacy-New Dosing Regimen
2 official documents Label ↗ 2024-12-03 · FDA document 80472 Letter ↗ 2024-11-29 · FDA document 80452 2024-11-01 · status AP
Supplement 21 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
2 official documents Label ↗ 2024-11-05 · FDA document 80134 Letter ↗ 2024-11-05 · FDA document 80129 2024-03-08 · status AP
Supplement 11 FDA action labels Efficacy-New Indication
3 official documents Review ↗ 2024-11-05 · FDA document 80167 Letter ↗ 2024-03-11 · FDA document 77775 Label ↗ 2024-03-08 · FDA document 77770 2023-07-21 · status AP
Supplement 7 FDA action labels Efficacy-New Dosing Regimen
2 official documents Label ↗ 2023-07-24 · FDA document 74874 Letter ↗ 2023-07-24 · FDA document 74868 2023-02-14 · status AP
Supplement 6 FDA action labels Labeling-Container/Carton Labels · Labeling-Medication Guide
2 official documents Letter ↗ 2023-02-16 · FDA document 73508 Label ↗ 2023-02-15 · FDA document 73507 2022-12-23 · status AP
Supplement 5 FDA action labels Efficacy-New Patient Population
2 official documents Letter ↗ 2022-12-27 · FDA document 73054 Label ↗ 2022-12-27 · FDA document 73036 2022-08-24 · status AP
Supplement 3 FDA action labels Labeling-Package Insert
1 official document Label ↗ 2022-08-29 · FDA document 71941 2021-06-04 · status AP
Original submission 1 No source action-type assignment was retained for this submission.
3 official documents Review ↗ 2021-12-27 · FDA document 69772 Letter ↗ 2021-06-07 · FDA document 67729 Label ↗ 2021-06-07 · FDA document 67724 Source archive dated 2026-08-24; observed 2026-08-24T21:23:49.000Z; reviewed 2026-08-24. Observation SHA-256: 6166fd223ef126a19e8ebfdaafe1fbf7c330a4cf7153cef00fb6c52c45ef757b.